Northern California Cancer Center, 2201 Walnut Ave, Suite 300, Fremont, CA 94538, USA.
Breast Cancer Res. 2007;9(5):R62. doi: 10.1186/bcr1768. Epub 2007 Sep 25.
Historically, the incidence rate of breast cancer among non-Hispanic white women living in the San Francisco Bay area (SFBA) of California has been among the highest in the world. Substantial declines in breast cancer incidence rates have been documented in the United States and elsewhere during recent years. In light of these reports, we examined recent changes in breast cancer incidence and risk factor prevalence among non-Hispanic white women in the SFBA and other regions of California.
Annual age-adjusted breast cancer incidence and mortality rates (1988 to 2004) were obtained from the California Cancer Registry and analyzed using Joinpoint regression. Population-based risk factor prevalences were calculated using two data sources: control subjects from four case-control studies (1989 to 1999) and the 2001 and 2003 California Health Interview Surveys.
In the SFBA, incidence rates of invasive breast cancer increased 1.3% per year (95% confidence interval [CI], 0.7% to 2.0%) in 1988-1999 and decreased 3.6% per year (95% CI, 1.6% to 5.6%) in 1999-2004. In other regions of California, incidence rates of invasive breast cancer increased 0.8% per year (95% CI, 0.4% to 1.1%) in 1988-2001 and decreased 4.4% per year (95% CI, 1.4% to 7.3%) in 2001-2004. In both regions, recent (2000-2001 to 2003-2004) decreases in invasive breast cancer occurred only in women 40 years old or older and in women with all histologic subtypes and tumor sizes, hormone receptor-defined types, and all stages except distant disease. Mortality rates declined 2.2% per year (95% CI, 1.8% to 2.6%) from 1988 to 2004 in the SFBA and the rest of California. Use of estrogen-progestin hormone therapy decreased significantly from 2001 to 2003 in both regions. In 2003-2004, invasive breast cancer incidence remained higher (4.2%) in the SFBA than in the rest of California, consistent with the higher distributions of many established risk factors, including advanced education, nulliparity, late age at first birth, and alcohol consumption.
Ongoing surveillance of breast cancer occurrence patterns in this high-risk population informs breast cancer etiology through comparison of trends with lower-risk populations and by highlighting the importance of examining how broad migration patterns influence the geographic distribution of risk factors.
历史上,加利福尼亚州旧金山湾区(SFBA)的非西班牙裔白人女性乳腺癌发病率一直位居世界前列。近年来,美国和其他地区的乳腺癌发病率已大幅下降。有鉴于此,我们研究了 SFBA 及加利福尼亚州其他地区非西班牙裔白人女性乳腺癌发病率和风险因素流行率的近期变化。
从加利福尼亚癌症登记处获取 1988 年至 2004 年的年龄调整后每年乳腺癌发病率和死亡率(1988 年至 2004 年),并使用 Joinpoint 回归进行分析。使用两个数据源计算基于人群的风险因素流行率:四项病例对照研究的对照受试者(1989 年至 1999 年)和 2001 年和 2003 年加利福尼亚健康访谈调查。
在 SFBA,1988 年至 1999 年,浸润性乳腺癌发病率每年增加 1.3%(95%置信区间 [CI],0.7%至 2.0%),1999 年至 2004 年每年下降 3.6%(95%CI,1.6%至 5.6%)。在加利福尼亚州的其他地区,1988 年至 2001 年,浸润性乳腺癌发病率每年增加 0.8%(95%CI,0.4%至 1.1%),2001 年至 2004 年每年下降 4.4%(95%CI,1.4%至 7.3%)。在这两个地区,最近(2000 年至 2001 年至 2003 年至 2004 年)浸润性乳腺癌发病率的下降仅发生在 40 岁及以上的女性以及所有组织学亚型和肿瘤大小、激素受体定义类型以及除远处疾病以外的所有阶段的女性中。1988 年至 2004 年,SFBA 和加利福尼亚州其他地区的死亡率每年下降 2.2%(95%CI,1.8%至 2.6%)。两个地区 2001 年至 2003 年间雌激素孕激素联合激素疗法的使用明显减少。2003 年至 2004 年,SFBA 的浸润性乳腺癌发病率仍高于加利福尼亚州其他地区(4.2%),这与许多已确立的风险因素分布较高有关,包括高等教育、未婚、初次生育年龄较晚和饮酒。
对高危人群乳腺癌发生模式的持续监测通过比较趋势与低危人群,并强调研究广泛的迁移模式如何影响风险因素的地理分布,从而通过比较趋势与低危人群来了解乳腺癌病因。